MAPT and Alzheimer disease: The missing link was made in 1986, when the same group demonstrated that antibodies to the PHF protein reacted specifically with tau [17], that antibodies to tau recognized some NFTs in post-mortem AD brain samples, and that this immunolabelling significantly increased after the tissue sections were chemically dephosphorylated [18].